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ABSTRACT 
 
    The µ (mu) opioid receptors, which mediate the effects of morphine, are widely distributed in brain. 
The purpose of this study was to design a simple expression system for rat µ-receptor in Escherichia coli 
(BL21). In this laboratory study, rat µ-receptor cDNA was isolated from pcDNA3 vector using Xba1 and 
Hind3 restriction enzymes. pET-15b was digested by Nco1 restriction enzyme. µ-receptor cDNA and 
pET-15b formed a recombinant DNA that was transformed to Escherichia coli (BL21). The insert 
presence was proved by Rsa1 restriction enzyme and the induction of its expression was performed using 
IPTG. Finally, the presence of desired insert was confirmed using RSA1, and the colonies that had 
correct orientation in gene containing plasmid were used for further studies. On the SDS-page gel 
electrophoresis, a 33 kDa band was observed when IPTG was used at 0.5 and 1 mM concentrations, that 
is equal to calculated molecular weight of rat µ-receptor. At the end of this project, the expression of rat 
µ-receptor by IPTG induction was successfully performed. 
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INTRODUCTION 
     Exogenous opioids and endogenous 
endorphins and enkephalins play a central role 
in pain relief and many other physiological 
activities [1]. The μ, δ, and κ, are the three main 
types of opioid receptors in the central and 
peripheral nervous system (CNS, PNS) [2-5]. 
But each type of these three receptors have the 
particular distribution [2-5]. Molecular analysis 
of opioid receptors suggests that these receptors 
belong to the G-pro coupled receptor super 
family. The most common cellular response of 
activation the opioid receptors is depression of 
neuronal excitability through various 
mechanisms such as inhibition of cAMP 
formation, increase in K
+
 channel and decrease 
in Ca
2+
 channel conductivity [6]. Depending on 
whether they are located on inhibitory or 
excitatory neurons, the whole effect of opioid 
receptors activation may be inhibition or 
excitation [7]. The µ-opioid receptors, which 
mediate the effects of morphine, are widely 
distributed in brain [8] and are very interest for 
several reasons; their propagation and 
pharmacologic properties place them among the 
other receptor most identified with the analgesic 
and addicting properties of opiate drugs [9-11]. 
µ-receptor is the main target for the production 
of clinical analgesia, [12] and this came about 
from the observations that some µ ligands could 
differentially affect the analgesic response and 
the unwanted respiratory depression [12].  
The expression of μ opioid receptor of different 
forms of animates was performed by many 
groups [1, 13] and the aim of this study is to 
construct the vector containing rat μ opioid 
receptor, express and optimize its expression in 
a suitable bacterial host cell for other surveys. 
 
MATERIALS AND METHODS 
Materials 
     E. coli BL21 was purchased from Cinnagen, 
Iran. The pET15b cloning and expression vector 
obtained from Novagen Co., USA. Calcium 
Chloride, Acetic acid, HCl, Ethanol, SDS, 
Potassium acetate, Sodium acetate, NaCl, and 
Glycerin were purchased from Merck, 
Germany. IPTG, Xba1, Hind3, Rsa1 and T4 
DNA ligase were purchased from Fementas, 
Poland. Luria-Bertani (LB) media was prepared 
according to the guidelines in the laboratory 
manual offered by Sambrook and Russell. 
Alkaline phosphatase, RNase, and agarose gel 
kit were purchased from Roche, Germany, 
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ampicilin was purchased from Sigma, USA, and 
aurum plasmid mini kit was provided from 
BioRad, USA. Finally the rat µ opoid receptor 
gene was kindly provided by Professor G. 
Henderson (Bristol, UK). 
Transformation of E. coli BL21 with 
recombinant pET15b plasmids 
     Five ml of the overnight culture of 
Escherichia coli (HB101) containing insert was 
centrifuged for 5 minutes. Supernatant was 
discarded, and the plasmid was extracted using 
commercial plasmid mini kit [14]. The sample 
was electerophoresed using 0.7% agarose gel. 
Digestion of pcDNA3 containing insert was 
performed by 1 µl of Xba1 and Hind3 
restriction enzymes for 1 hr at 37 °C and then 
electerophoresed.  The agarose gel containing 
DNA insert was cut, weighed and added to the 
buffer solution at 50 °C for 10 minutes until the 
gel was completely dissolved. Separation of the 
insert was performed using silica column. The 
amount of insert was determined with agarose 
gel electrophoresis compared to λ marker.  On 
the other hand, pET-15b was digested by 1 µl of 
Nco1 restriction enzyme. Finally 6 µl pET-15b 
and 1 µl alkaline phosphatase were incubated 
for 5 minutes at 70 °C to dephosphorylate pET-
15b and prevent the formation of incorrect 
circular DNA. Ligation of pET-15b with 
extracted insert was performed with 1 µl insert, 
15 µl pET-15b, 2 µl DNA ligase T4 and 2 µl 
buffer at 16 °C and for about 2 hrs. Preparation 
of competent Escherichia coli (BL21) and 
transformation of it was performed using 
calcium chloride and heat shock method 
respectively. Colonies from plates containing a 
recombinant DNA were cultured in 5 ml LB 
medium and were incubated overnight at 37 °C 
[15]. The next day, plasmids were extracted. 
One µl of plasmid was digested by Rsa1 
restriction enzyme and was analyzed on agarose 
gel electrophoresis [16, 17].  
Expression of rat µ-receptor 
     One of the colonies was transferred to 5 ml 
LB culture and was incubated overnight. After 
24 hrs, 1 ml of overnight culture was added to 
50 ml LB containing 100 µg/ml ampicillin. 
When the OD reached to 0.58, the culture was 
divided in to five 10 ml cultures. Two cultures 
were induced by two concentrations of IPTG 
(0.5 and 1 mM). The culture that contained 
pET-15b without the insert was used for 
comparison with samples containing insert. 
Two samples that were used for induction by 
IPTG, were added to the culture that was 
induced. IPTG 0.5 mM was also added to the 
fifth culture. Finally, OD for all samples was 
measured at 2 and 4 hrs after induction of 
cultures. Finally all samples were analyzed 
using SDS-page electerophoresis [18]. 
Determination of µ-receptor molecular weight  
    According to the Rf (rate of relative motion) 
of the standard protein on SDS gel 
electerophoresis, the molecular weight of 
proteins were determined in the linear range. 
 
RESULTS 
Digestion of pcDNA3 containing insert by 
restriction enzymes 
     After extraction of pcDNA3 containing 
insert from Escherichia coli (HB101), the DNA 
fragments were analyzed on 0.7% agarose gel 
electrophoresis to confirm the presence of insert 
(Figure 1).  
 
 
 Figure 1. Electrophoresis of pcDNA3 containing insert 
on 0.7% agarose gel. 
 
 
Figure 2. Electrophoresis of digested pcDNA3 
containing insert by restriction enzymes (Xba1 and 
Hind3). Lane 1, DNA marker and Lane 2 the plasmid 
DNA (5428) containing an insert (1291). 
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Digestion of pcDNA3 containing insert by 
restriction enzymes (Xba1 and Hind3), resulted 
in production of two fragments: the plasmid 
DNA (5.4 kb) and the insert (1.2 kb). These two 
fragments were detected using 0.7% agarose gel 
electrophoresis (Figure 2).  
Transformation of Escherichia coli (BL21) 
with pET-15b containing insert 
After extraction of pET-15b from Escherichia 
coli (BL21), the DNA fragments were separated 
on agarose gel (0.7%) to confirm the presence 
of insert (Figure 3).  
The linear pET-15b and the insert extracted 
from the gel after the digestion the pcDNA3, 
were cut from gel and their weights were 
determined by λ marker. Values of the pET-15b 
and the insert were as follows: (Figure 4) 
 
Vector (elution 1): 3.9 ng/µl  Vector (elution 1): 3.9 ng/µl 
Insert (elution 2): 64.9 ng/µl     Insert (elution 2): 40 ng/µl   
 
Figure 3. Electrophoresis of pET-15b containing insert 
on 0.7% agarose gel. 
Lanes 1-10: extracted plasmids from transformed 
Escherichia coli (HB101) with pET-15b.  
 
Analysis of pET-15b containing insert by 
restriction enzyme 
pET-15b containing insert and plasmid without 
insert was cut by the Rsa1 restriction enzyme. 
The results showed that two colonies have the 
correct gene orientation, and for two colonies 
the gene are linked wrongly to the plasmid. 
Colonies with the correct gene orientation 
created 5 bands in agarose gel electrophoresis at 
about 1500, 1300, 746, 60 and 2263, and 
Colonies with the wrong gene orientation 
created 4 bands at about 1500, 580, 680 and 
2263 (Figure 5). 
 
 
Figure 4. Digestion of DNA by HindIII and 
determination its size using λ Hind3 marker. Column 1: 
λ Hind3 marker, 2: 100 bp marker, 3: extracted insert 
from pcDNA3 (elution 2), 4: extracted insert from 
pcDNA3 (elution 1), 5: digested pET-15b (elution 2), 
and 6: digested pET-15b (elution 1). 
 
 
Figure 5. Electrophoresis of  pET-15b containing insert 
by restriction enzyme RsaI. Column 1: 100 bp marker, 
2 and 3: pET-15b containing insert in correct 
orientation, 4 and 5: pET-15b containing insert in 
incorrect orientation, and 6: pET-15b without insert 
digested by restriction enzyme RsaI. 
 
Determination of µ-receptor molecular weight 
In SDS-page gel electerophoresis, in addition to 
the other bands, a band in the induced samples 
was observed at about 33 KDa. By using of the 
standard samples with particular molecular 
weight, the diagram of the logarithm of 
molecular weight was plotted against of Rf, 
molecular weight receptor was estimated at 
about 33 KD (Figure 6). 
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Figure 6.  SDS- page electrophoresis of rat µ-receptor protein, Lane 1: molecular weight marker. Lanes 2 and 7: protein 
sample of pET-15b without insert 4 and 2 hrs after induction using IPTG respectively. Lanes 3 and 5: protein sample of 
pET-15b with insert 4 hrs after expression without induction. Lanes 6 and 11: protein sample of pET-15b with insert 4 
and 2 hrs after induction using IPTG 0.5 mM respectively. Lane 4 and 9: protein sample of pET-15b with insert 4 and 2 
hrs after induction using IPTG 1 mM respectively. 
 
DISCUSSION 
      The purpose of this project was to express 
the rat µ-receptor gene in Escherichia coli 
(BL21). Escherichia coli (BL21) is able to grow 
in minimal medium, and is non-pathogen too. It 
lacks the genes encoding proteases such as 
ompT and Ion [19, 20], that are involved in 
degradation  of the final recombinant proteins. 
Expression vector pET-15b system is based on 
T7 promoter that has been used in the 
production of recombinant proteins. This 
promoter is induced by IPTG [19]. pET-15b 
vector has several advantages over other vectors 
including high copy number (20-50 per cell) 
and has a His-tag sequence so the purification 
of the recombinant protein is facilitated using 
affinity chromatography. 
The target gene was inserted into pET-15b and 
its orientation was analyzed by Rsa1 restriction 
enzyme. Since the Rsa1 restriction enzyme has 
4 digestion sites in pET-15b, and three on the 
insert, the digestion of the recombinant vector 
in the right orientation should result in creation 
of 7 appropriate fragments sizes (142, 180, 680, 
746, 1330, 1567 and 2263). IPTG induction at 
0.5 and 1 mM showed no difference on the 
strength of protein band that was observed at 
approximately 33 kDa. It seems that the optimal 
concentration for IPTG in this expression 
system is between 0.5 and 1 mM. Other studies 
have also used these concentration of IPTG and 
the induction was successfully performed [21]. 
Stanisila et.al expressed the human µ-receptor 
in E.coli in different temperature (20, 30, and 37 
ºC) and 0.5 mM, concluded that lower 
temperature help to increase the amount of 
expressed receptor. It was due to the correct 
folding of the recombinant protein [20]. Thus it 
is suggested the use of lower temperature and 
concentration of IPTG for optimizing the 
expression of this receptor. 
In some studies by Chen Y, et al and Thompson 
RC, et al, the expression of rat µ-receptor was 
performed and the  recent  cloning  of  µ-
receptor gene [22-24] suggests that  it  is  a  397  
amino  acid  protein and 1197 bp cDNA that  is  
homologous  to  other  seven  transmembrane  
G-pro  coupled receptors.  The  cloned rat µ-
receptor  has  high  homology to the  δ [23, 25, 
26]  and  κ [27, 28]  opioid  receptors,  
particularly  in  transmembrane  domains  I-III  
and  V-VII,  as well  as  in  the  putative  
intracellular  loop.  
  In this project, we designed a simple system 
for expression of rat µ-receptor. So it can be 
increase the level of production of the 
recombinant µ-receptor by change the induction 
condition such as the concentration of IPTG and 
the bacterial growth temperature. Also we can 
use of other expression systems such as yeasts 
and other eukaryotic organisms for post 
translation modification. Research project 
number: 83287, Isfahan University of medical 
sciences. 
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